Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
23.39
+0.35 (1.52%)
At close: Feb 27, 2026, 4:00 PM EST
22.93
-0.46 (-1.97%)
After-hours: Feb 27, 2026, 7:41 PM EST
Ultragenyx Pharmaceutical Employees
Ultragenyx Pharmaceutical had 1,371 employees as of December 31, 2025. The number of employees increased by 77 or 5.95% compared to the previous year.
Employees
1,371
Change (1Y)
77
Growth (1Y)
5.95%
Revenue / Employee
$520,093
Profits / Employee
-$444,359
Market Cap
2.26B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,869 |
| Telix Pharmaceuticals | 1,184 |
| Adaptive Biotechnologies | 619 |
| Ascentage Pharma Group International | 605 |
| Galapagos NV | 558 |
| Immunome | 168 |
| Stoke Therapeutics | 128 |
| Mesoblast | 81 |
RARE News
- 4 days ago - Ultragenyx Pharmaceutical Inc. (RARE) Securities Fraud: Contact Berger Montague To Discuss Your Rights - Newsfile Corp
- 5 days ago - Ultragenyx to Participate at Investor Conferences in March - GlobeNewsWire
- 5 days ago - Ultragenyx Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application (BLA) for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa) - GlobeNewsWire
- 8 days ago - Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 10 days ago - Stockholders Who Lost Money Investing in Ultragenyx Pharmaceutical Inc. Should Contact Robbins LLP for Information About Recovering Their Losses from RARE - GlobeNewsWire
- 15 days ago - Ultragenyx Pharmaceutical Inc. (RARE) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Why Is Ultragenyx Stock Sinking Friday? - Benzinga
- 16 days ago - Ultragenyx Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Update - GlobeNewsWire